Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-303 Treated RBCs in Thalassemia Major
NCT01740531Phase 3Completed
- Sponsor
- Cerus Corporation
- Start
- Dec 2012
- Primary completion
- Dec 2017
- Modality
- Small Molecules, Cell Therapies
- Countries
- 2
01
Overview
A Phase 3 trial of amustaline in beta thalassemia major, sponsored by Cerus Corporation. Started Dec 2012; status: completed.
02
Drugs
amustaline
03
Conditions
beta thalassemia major
Beyond the preview
Go deeper on NCT01740531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01740531.